IL2 and acute myeloid leukemia: To evaluate whether NPM1mut-CTLs could be expanded from the peripheral blood of AML patients in remission, and potential stem cell donors, PBMC were stimulated or primed with autologous DC pulsed with the NPM1mut-peptide pool in the presence of IL2 and IL15.